Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months

NCT02579759 is registered in ClinicalTrials.gov with Pharnext S.C.A. as lead sponsor.

NCT NCT02579759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study Assessing in Parallel Groups the Efficacy and Safety of 2 Doses of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Treated 15 Months
Lead sponsor
Pharnext S.C.A.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
August 31, 2018
Enrollment
323 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

charcot-marie-tooth disease type 1a